After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension

  1. Tamargo, J.
Aldizkaria:
European heart journal. Cardiovascular pharmacotherapy

ISSN: 2055-6845

Argitalpen urtea: 2024

Alea: 10

Zenbakia: 5

Orrialdeak: 371-373

Mota: Artikulua

DOI: 10.1093/EHJCVP/PVAE035 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus